3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
9
Lung Neoplasms
5
Melanoma
3
Neoplasms
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Thyroid Neoplasms
1
Prostatic Neoplasms
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Liposarcoma
1
Glioma
1
Gastrointestinal Stromal Tumors
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma
1
Brain Neoplasms
1
Brain Diseases
1
Advanced Non-small Cell Lung Cancer
1
Adenocarcinoma of Lung
1
Interventions
belinostat
2
Fulvestrant
2
sodium thiosulfate
1
pembrolizumab
1
enzalutamide
1
cemiplimab
1
X-Rays
1
Therapeutics
1
Specimen Handling
1
Radiation, Ionizing
1
Quality of Life
1
Platinum
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Midazolam
1
Magnetic Resonance Spectroscopy
1
Letrozole
1
Immunotherapy
1
Imatinib Mesylate
1
Hyperthermic Intraperitoneal Chemotherapy
1
Histamine H2 Antagonists
1
Fluorouracil
1
Famotidine
1
Drug Therapy
1
Doxorubicin
1
Docetaxel
1
Cytoreduction Surgical Procedures
1
Cisplatin
1
Biological Therapy
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liposarcoma
×
Midazolam
×
Thoracic
×
Clear all
NCT04557449
2025-10-01
CDK4i
Pfizer
Phase 2
Active not recruiting
362 enrolled